Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies. (Q36670916)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

review article

1 reference

title

Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Mario Tumbarello

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Matteo Bassetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Claudio Viscoli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Raffaella Rosso

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

875-885

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of nosocomial fungal infections, with emphasis on Candida species

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

The epidemiology of candidemia in two United States cities: results of a population-based active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Candidemia in a pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Epidemiological trends in nosocomial candidemia in intensive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Effect of fluconazole consumption on long-term trends in candidal ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Fungal infections: current diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Candida colonization and subsequent infections in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Temporal assessment of Candida risk factors in the surgical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Effects of nosocomial candidemia on outcomes of critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Increased levels of Candida albicans mannan-specific T-cell-derived antigen binding molecules in patients with invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Reply to Dr. Chandrasekar (Clin Infect Dis 2001; 32:320-1) and Drs. Marr and Boeckh (Clin Infect Dis 2001; 32:321).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Clinical trials of antifungal prophylaxis among patients in surgical intensive care units: concepts and considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Antifungal prophylaxis for intensive care unit patients: let's fine tune it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Clinical and economic outcomes of conventional amphotericin B-associated nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Role of interleukin-18 in host defense against disseminated Candida albicans infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

New perspectives on the immunology of chronic mucocutaneous candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Candida spp. colonization significance in critically ill medical patients: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Fungemia in cancer patients in Brazil: predominance of non-albicans species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

Candidemia in intensive care unit patients: Risk factors for mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.5.875

21 January 2018

Identifiers

DOI

10.1586/14787210.4.5.875

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17140362%20AND%20SRC:MED&resulttype=core&format=json